Yoo J, Kim J, Cho H, Han J, Jang J, Choi J
Abdom Radiol (NY). 2024; 49(9):3127-3135.
PMID: 38678485
DOI: 10.1007/s00261-024-04308-6.
Masuda T, Niizeki O, Niizeki T, Fujiyoshi K, Ando Y, Niizeki H
Case Rep Oncol. 2021; 14(3):1261-1265.
PMID: 34720925
PMC: 8460923.
DOI: 10.1159/000517854.
Laface C, Laforgia M, Molinari P, Ugenti I, Gadaleta C, Porta C
Cancers (Basel). 2021; 13(12).
PMID: 34205656
PMC: 8234226.
DOI: 10.3390/cancers13123091.
Liu S, Lai J, Lyu N, Xie Q, Cao H, Chen D
Front Oncol. 2021; 10:582504.
PMID: 33614477
PMC: 7890701.
DOI: 10.3389/fonc.2020.582504.
Gou Q, Wu L, Cui W, Mo Z, Zeng D, Gan L
Eur Radiol. 2021; 31(8):5851-5862.
PMID: 33585991
PMC: 8270826.
DOI: 10.1007/s00330-021-07716-0.
Determinants of pain in advanced HCC patients recieving hepatic artery infusion chemotherapy.
Wu Z, Guo W, Chen S, Zhuang W
Invest New Drugs. 2020; 39(2):394-399.
PMID: 33006020
PMC: 7960585.
DOI: 10.1007/s10637-020-01009-x.
Chinese expert consensus and practice guideline of totally implantable access port for digestive tract carcinomas.
Zhang K, Chen L
World J Gastroenterol. 2020; 26(25):3517-3527.
PMID: 32742123
PMC: 7366063.
DOI: 10.3748/wjg.v26.i25.3517.
Celiomesenteric trunk: New classification based on multidetector computed tomography angiographic findings and probable embryological mechanisms.
Tang W, Shi J, Kuang L, Tang S, Wang Y
World J Clin Cases. 2019; 7(23):3980-3989.
PMID: 31832400
PMC: 6906573.
DOI: 10.12998/wjcc.v7.i23.3980.
Complications arising from transfemoral, percutaneous implantation of an indwelling port-catheter system for hepatic infusion chemotherapy: Case series of the management and salvage of the system.
Ueda M, Sai K, Sonoda T, Tanaka M, Shibaoka Y
Int J Surg Case Rep. 2019; 65:78-82.
PMID: 31689634
PMC: 6838975.
DOI: 10.1016/j.ijscr.2019.10.017.
Japanese patient preferences regarding intermediate to advanced hepatocellular carcinoma treatments.
Chiba T, Hiraoka A, Mikami S, Shinozaki M, Osaki Y, Obu M
Patient Prefer Adherence. 2019; 13:637-647.
PMID: 31118587
PMC: 6503324.
DOI: 10.2147/PPA.S198363.
Clinical modalities for management of gastric cancer hepatic metastasis.
Tao F, Lv J, Wang W, Jin K
Int J Clin Exp Med. 2016; 8(11):19850-8.
PMID: 26884895
PMC: 4723740.
Intrahepatic therapy for liver-dominant metastatic colorectal cancer.
De Groote K, Prenen H
World J Gastrointest Oncol. 2015; 7(9):148-52.
PMID: 26380058
PMC: 4569592.
DOI: 10.4251/wjgo.v7.i9.148.
Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma.
Song M
World J Gastroenterol. 2015; 21(13):3843-9.
PMID: 25852268
PMC: 4385530.
DOI: 10.3748/wjg.v21.i13.3843.
Newer treatments for advanced hepatocellular carcinoma.
Song M, Bae S
Korean J Intern Med. 2014; 29(2):149-55.
PMID: 24648795
PMC: 3956982.
DOI: 10.3904/kjim.2014.29.2.149.
Treatment of gastric cancer.
Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, Laterza M
World J Gastroenterol. 2014; 20(7):1635-49.
PMID: 24587643
PMC: 3930964.
DOI: 10.3748/wjg.v20.i7.1635.
Intra-arterial therapies for metastatic colorectal cancer.
Wang D, Louie J, Sze D
Semin Intervent Radiol. 2014; 30(1):12-20.
PMID: 24436513
PMC: 3700785.
DOI: 10.1055/s-0033-1333649.
Current status of hepatocellular carcinoma treatment in Japan: hepatic arterial infusion chemotherapy.
Yamashita T
Clin Drug Investig. 2012; 32 Suppl 2:15-23.
PMID: 22873624
DOI: 10.1007/BF03265493.
Hepatic arterial infusion chemotherapy with a coaxial reservoir system using a non-braided spiral tip microcatheter.
Koganemaru M, Abe T, Iwamoto R, Nonoshita M, Yoshida S, Uchiyama D
Jpn J Radiol. 2011; 30(1):10-7.
PMID: 22135111
DOI: 10.1007/s11604-011-0001-3.
Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma.
Kim B, Park J, Choi H, Kim D, Ahn S, Kim J
J Cancer Res Clin Oncol. 2010; 137(4):659-67.
PMID: 20552225
DOI: 10.1007/s00432-010-0917-5.
Strategies for treating liver metastasis from gastric cancer.
Kakeji Y, Morita M, Maehara Y
Surg Today. 2010; 40(4):287-94.
PMID: 20339981
DOI: 10.1007/s00595-009-4152-0.